Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Optiscan Targets US Rollout After Filing Two Human Device Applications

OIL: $0.145 -6.45% · MC: $162M

Optiscan Imaging says it filed US regulatory applications for its InForm and InVue human imaging devices in October, with clearances anticipated from October next year, subject to review. The company plans to place consoles at up to five US reference sites before expanding to its first customer accounts. Its first own-brand clinical product, InSpecta, launched in the US veterinary market in July.

Source announcements: 2026-11-17 08:47 to 2026-11-17 08:47 Sydney time
Story updated 2026-11-17 10:38 Sydney time
SourcesBell Potter Healthcare Conference Presentation
Comments